The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Magnetic nanoparticles with dual functional properties: Drug delivery and magnetic resonance imaging
Open accessAbstract
There is significant interest in recent years in developing MNPs having multifunctional characteristics with complimentary roles. In this study, we investigated the drug delivery and magnetic resonance imaging (MRI) properties of our novel oleic acid-coated iron-oxide and pluronic-stabilized magnetic nanoparticles (MNPs). The drug incorporation efficiency of doxorubicin and paclitaxel (alone or in combination) in MNPs was 74–95%; the drug release was sustained and the incorporated drugs had marginal effects on physical (size and zeta potential) or magnetization properties of the MNPs. The drugs in combination incorporated in MNPs demonstrated highly synergistic antiproliferative activity in breast cancer cells. The T2 relaxivity (r2) was higher for our MNPs than Feridex IV, whereas the T1 relaxivity (r1) was better for Feridex IV than for our MNPs, suggesting greater sensitivity of our MNPs than Feridex IV in T2 weighted imaging. The circulation half-life (t1/2), determined from the changes in the MRI signal intensity in carotid arteries in mice, was longer for our MNPs than Feridex IV (t1/2 = 31.2 vs 6.4 min). MNPs with combined characteristics of MRI and drug delivery could be of high clinical significance in the treatment of various disease conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abràmoff, M. D., Magalhães, P. J., & Ram, S. J. (2004) · Utrecht University Repository (Utrecht University) · Cited by 15,104
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Promotion of microtubule assembly in vitro by taxol
SCHIFF, P. B., FANT, J., & HORWITZ, S. B. (1979) · Nature · doi:10.1038/277665a0 · Cited by 3,600
Vogel's textbook of quantitative chemical analysis
Vogel, A. I., & Jeffery, G. H. (1989) · Medical Entomology and Zoology · Cited by 2,256
Hyperthermia in combined treatment of cancer
Wust, P., Hildebrandt, B., Sreenivasa, G., Rau, B., Gellermann, J., Riess, H., Felix, R., & Schlag, P. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00818-5 · Cited by 1,998
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
A clinicopathologic analysis of adriamycin cardiotoxicity
Lefrak, E. A., Piťha, J., Rosenheim, S., & Gottlieb, J. A. (1973) · Cancer · doi:10.1002/1097-0142(197308)32:2<302::aid-cncr2820320205>3.0.co;2-2 · Cited by 1,560
Jordan, A., Scholz, R., Wust, P., Fähling, H., & Felix, R. (1999) · Journal of Magnetism and Magnetic Materials · doi:10.1016/s0304-8853(99)00088-8 · Cited by 1,494
Wang, Y.-X. J., Hussain, S. M., & Krestin, G. P. (2001) · European Radiology · doi:10.1007/s003300100908 · Cited by 1,381
Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells
Bulte, J. W. M., Douglas, T., Witwer, B., Zhang, S.-C., Strable, E., Lewis, B. K., Zywicke, H., Miller, B., van Gelderen, P., Moskowitz, B. M., et al. (2001) · Nature Biotechnology · doi:10.1038/nbt1201-1141 · Cited by 1,027
Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo
Scherer, F., Anton, M., Schillinger, U., Henke, J., Bergemann, C., Krüger, A., Gänsbacher, B., & Plank, C. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301624 · Cited by 932
Iron Oxide Nanoparticles for Sustained Delivery of Anticancer Agents
Jain, T. K., Morales, M. A., Sahoo, S. K., Leslie-Pelecky, D. L., & Labhasetwar, V. (2005) · Molecular Pharmaceutics · doi:10.1021/mp0500014 · Cited by 904
Self-citationSurface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
Storm, G., Belliot, S. O., Daemen, T., & Lasic, D. D. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00039-a · Cited by 877
Locoregional cancer treatment with magnetic drug targeting.
Alexiou, C., Arnold, W. J., Klein, R. J., Parak, F., Hulin, P., Bergemann, C., Erhardt, W. D., Wagenpfeil, S., & Lübbe, A. S. (2000) · PubMed · Cited by 863
In Vivo Magnetic Resonance Detection of Cancer by Using Multifunctional Magnetic Nanocrystals
Huh, Y.-M., Jun, Y.-W., Song, H.-T., Kim, S., Choi, J.-S., Lee, J.-H., Yoon, S., Kim, K.-S., Shin, J.-S., Suh, J.-S., et al. (2005) · Journal of the American Chemical Society · doi:10.1021/ja052337c · Cited by 859
Johannsen, M., Gneveckow, U., Eckelt, L., Feussner, A., WaldÖFner, N., Scholz, R., Deger, S., Wust, P., Loening, S. A., & Jordan, A. (2005) · International Journal of Hyperthermia · doi:10.1080/02656730500158360 · Cited by 798
Long circulating microparticulate drug carriers
Stolnik, S., Illum, L., & Davis, S. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00025-3 · Cited by 700
Lübbe, A. S., Bergemann, C., Riess, H. B., Schriever, F., Reichardt, P., Possinger, K., Matthias, M., Dörken, B., Herrmann, F., Gürtler, R., et al. (1996) · PubMed · Cited by 652
Microvascular permeability of normal and neoplastic tissues
Gerlowski, L. E., & Jain, R. K. (1986) · Microvascular Research · doi:10.1016/0026-2862(86)90018-x · Cited by 622
Jung, C. W., & Jacobs, P. (1995) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(95)00024-b · Cited by 622
Analysis of combined drug effects: a new look at a very old problem
Chou, T.-C., & Talalay, P. (1983) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(83)90490-x · Cited by 619
Magnetic separation techniques in diagnostic microbiology
Olsvik, O., Popovic, T., Skjerve, E., Cudjoe, K. S., Hornes, E., Ugelstad, J., & Uhlén, M. (1994) · Clinical Microbiology Reviews · doi:10.1128/cmr.7.1.43 · Cited by 504
Chouly, C., Pouliquen, D., Lucet, I., Jeune, J. J., & Jallet, P. (1996) · Journal of Microencapsulation · doi:10.3109/02652049609026013 · Cited by 467
Topoisomerase-targeting antitumor drugs
D'Arpa, P., & Liu, L. F. (1989) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(89)90041-3 · Cited by 434
Magnetic Polystyrene Nanoparticles with a High Magnetite Content Obtained by Miniemulsion Processes
Ramírez, L. P., & Landfester, K. (2003) · Macromolecular Chemistry and Physics · doi:10.1002/macp.200290052 · Cited by 429
Kohler, N., Sun, C., Fichtenholtz, A., Gunn, J., Fang, C., & Zhang, M. (2006) · Small · doi:10.1002/smll.200600009 · Cited by 424
Preparation and Properties of Magnetite and Polymer Magnetite Nanoparticles
Dresco, P. A., Zaitsev, V. S., Gambino, R. J., & Chu, B. (1999) · Langmuir · doi:10.1021/la980971g · Cited by 373
Understanding microtubule dynamics for improved cancer therapy
Honore, S., Pasquier, E., & Braguer, D. (2005) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-005-5330-x · Cited by 319
Moghimi, S. M., Muir, I. S., Illum, L., Davis, S. S., & Kolb-Bachofen, V (1993) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(93)90137-e · Cited by 259
Rudge, S. R., Kurtz, T. L., Vessely, C. R., Catterall, L. G., & Williamson, D. L. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00006-5 · Cited by 233
Kim, S. Y., & Lee, Y. M. (2001) · Biomaterials · doi:10.1016/s0142-9612(00)00292-1 · Cited by 227
Tan, J. S., Butterfield, D. E., Voycheck, C. L., Caldwell, K. D., & Li, J. T. (1993) · Biomaterials · doi:10.1016/0142-9612(93)90004-l · Cited by 191
Adriamycin Cardiotoxicity in Man
RINEHART, J. J., LEWIS, R. P., & BALCERZAK, S. P. (1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-4-475 · Cited by 190
Westbrook, C., & Roth, C. K. (1993) · Medical Entomology and Zoology · Cited by 180
A Novel Polyacrylamide Magnetic Nanoparticle Contrast Agent for Molecular Imaging using MRI
Moffat, B. A., Reddy, G. R., McConville, P., Hall, D. E., Chenevert, T. L., Kopelman, R. R., Philbert, M., Weissleder, R., Rehemtulla, A., & Ross, B. D. (2003) · Molecular Imaging · doi:10.1162/15353500200303163 · Cited by 158
Delivery of diagnostic agents for magnetic resonance imaging
Okuhata, Y. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00103-3 · Cited by 145
Zhang, J., Zhang, Z.-H., Yang, H., Tan, Q., Qin, S.-R., & Qiu, X.-L. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-2496-8 · Cited by 123
Dandamudi, S., & Campbell, R. B. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.07.024 · Cited by 118
Biodegradation of magnetite dextran nanoparticles in the rat. A histologic and biophysical study.
Okon, E. E., Pouliquen, D., Okon, P., Zv, K., Tp, S., Sg, L., Kudryavtsev, B. N., & JALLET, P. (1994) · PubMed · Cited by 117
In vivo imaging of tumor response to therapy using a dual‐modality imaging strategy
Medarova, Z. O., Pham, W. N., Kim, Y. R., Dai, G., & Moore, A. V. (2005) · International Journal of Cancer · doi:10.1002/ijc.21672 · Cited by 110
The application of Fe3O4 nanoparticles in cancer research: A new strategy to inhibit drug resistance
Wang, X., Zhang, R., Wu, C., Dai, Y.-Y., Song, M., Gutmann, S., Gao, F., Lv, G., Li, J., Li, X., et al. (2006) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30901 · Cited by 95
Clinical relevance of the molecular mechanisms of resistance to anti-cancer drugs
Brown, R. E., & Links, M. J. (1999) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399499001099x · Cited by 85
Hamoudeh, M., Faraj, A. A., Canet‐Soulas, E., Bessueille, F., Léonard, D., & Fessi, H. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.01.023 · Cited by 82
Chattopadhyay, P., & Gupta, R. B. (2002) · Industrial & Engineering Chemistry Research · doi:10.1021/ie020205b · Cited by 80
Arias, J. L., Ruíz, M. A., Gallardo, V., & Delgado, Á. V. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.09.008 · Cited by 80
Kubo, T., Sugita, T., Shimose, S., Nitta, Y., Ikuta, Y., & Murakami, T. (2001) · International Journal of Oncology · doi:10.3892/ijo.18.1.121 · Cited by 79
Targeting of drugs 6 : strategies for stealth therapeutic systems
Gregoriadis, G. C. (1998) · Plenum Press eBooks · Cited by 56
HLA-B27 and disease pathogenesis: new structural and functional insights
Bowness, P., Zaccai, N. R., Bird, L., & Jones, E. Y. (1999) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399499001118 · Cited by 41
Niethammer, A. G., Gaedicke, G., Lode, H. N., & Wrasidlo, W. (2001) · Bioconjugate Chemistry · doi:10.1021/bc000122g · Cited by 38
Cited by
Mahmoudi, M., Sant, S., Wang, B., Laurent, S., & Sen, T. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.05.006 · Cited by 1,881
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
Veiseh, O., Gunn, J. W., & Zhang, M. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.002 · Cited by 1,832
Nanoparticle-based theranostic agents
Xie, J., Lee, S., & Chen, X. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.009 · Cited by 1,422
Rasmussen, J. W., Martinez, E., Louka, P., & Wingett, D. G. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2010.502560 · Cited by 1,330
Nanomaterials for Theranostics: Recent Advances and Future Challenges
Lim, E.-K., Kim, T., Paik, S., Haam, S., Huh, Y.-M., & Lee, K. (2015) · Chemical Reviews · doi:10.1021/cr300213b · Cited by 1,233
Metadata
- Authors
- Jain, T. K., Richey, J., Strand, M., Leslie-Pelecky, D. L., Flask, C. A., & Labhasetwar, V.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2008-10
- Volume
- 29
- Issue
- 29
- Pages
- 4012-4021
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2037868353
- Cited by
- 491
- References
- 50
- FWCI
- 12.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.